We are monitoring the impact of COVID-19 on MEA Electroceuticals Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 7029
Share on
Share on

Middle East & Africa Electroceuticals Market Research Report - Segmented By Product, Type Of Device, Application, End User, and Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 7029
Pages: 145

MEA Electroceuticals Market Size (2021 to 2026)

The Middle East and Africa Electroceuticals Market size have been valued at USD 1.74 billion in 2021. It is estimated to be growing at a CAGR of 8% and worth USD 2.55 billion by 2026.

Electroceuticals are devices that use electrical impulse for treating ailments; therefore, due to increase in the technological advancements for developing innovative devices and effective treatment for treating ailments such as wearable and implantable devices, for instance, vagal nerve stimulation is a technique that stimulates the vagus nerve with electrical impulse and currently, FDA approved vagus nerve stimulator to treat epilepsy and depression which is driving the demand for the Middle East & Africa electroceuticals market. 

The growth of the MEA electroceuticals market is increasing due to the rising prevalence of chronic diseases such as diabetes, cardiovascular diseases, and other heart-related diseases and neurological diseases such as epilepsy and many other disorders related to neurological disorders is increasing the demand in the market. Also, an increase in the growing elderly population with the diseases such as Alzheimer's and Parkinson's diseases helps propel the growth of the Middle East & Africa Electroceuticals Market.

Furthermore, increase in the investment and funding from government and non-government organizations in research and development activities for manufacturing innovative devices and therapies as well as medication. Also, the increase in initiatives for growing awareness about the benefits and applications of electroceuticals among the people is uplifting the market growth. In addition, the regulatory approvals for introducing new innovative products and services in the market also increase the market's development.

However, the increase in the costs of installation and maintenance of the devices is majorly restraining the market's growth. Also, the strict government rules and regulations with the lack of proper reimbursement policies hamper the growth of the MEA electroceuticals market.

In addition, an increase in the costs of devices and treatment with the lack of awareness among the people about the availability of advanced treatment and procedures in the market are also hampering the growth of the Middle East & Africa electroceuticals market. Another factor that is limiting the market is the recalling of the product or services that would create consequences for the company.

This research report on the Middle East and Africa Electroceuticals market has been segmented and sub-segmented into the following categories:

By Product: 

  • Pacemakers

  • Cochlear Implants

  • Spinal Cord Stimulators

By Type Of Device: 

  • Implantable

  • Non-Invasive

By Application: 

  • Arrhythmia

  • Depression

  • Migraine

By End User: 

  • Hospitals

  • Research Institutes

By Country: 

  • KSA

  • UAE

  • Israel

  • rest of GCC countries

  • South Africa

  • Ethiopia

  • Kenya

  • Egypt

  • Sudan

  • rest of MEA

Geographically, The Middle East and Africa Electroceuticals market are anticipated to witness a moderates share during the forecast period. The market growth is attributed to the improving healthcare infrastructure, increasing healthcare spending, and increasing investments by the government. In addition, the growing elderly population, increasing prevalence of chronic disease and neurological diseases are majorly fuelling the growth of the MEA electroceuticals market. The easing prevalence of Alzheimer's and Parkinson's diseases among the people, therefore, in UAE more than 10,000 people have this Parkinson's disease and in Saudi Arabia is estimated to have 27 per 1 lakh people is increasing the market growth of electroceuticals.

South Africa recorded the largest share of the MEA Electroceuticals market, and it is likely to continue its growth during the forecast period. Increasing disposable income of the individuals, well-equipped medical and healthcare infrastructure, and growing government initiatives boost market growth.

UAE is more likely to showcase a significant growth in the MEA electroceuticals market due to an increase in focus towards adopting technological advancements in developing innovative and effective treatments for treating diseases with the growing awareness among the people about electroceuticals benefits to growth in the market.

Noteworthy companies leading in the MEA Electroceuticals Market profiled in the report are Medtronic plc, St. Jude Medical, Inc., Boston Scientific Corporation, Cochlear Limited, Sonova Holding AG, LivaNova PLC, Biotronik, Nevro Corporation, Second Sight Medical Products, Inc., and ElectroCore LLC.

1. Introduction         

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods 

                1.4 General Study Assumptions                

2. Research Methodology                  

                2.1 Introduction      

                2.2 Research Phases                      

       2.2.1 Secondary Research           

       2.2.2 Primary Research 

       2.2.3 Econometric Modelling      

       2.2.4 Expert Validation  

                2.3 Analysis Design

                2.4 Study Timeline 

3. Overview              

                3.1 Executive Summary                

                3.2 Key Inferences

                3.3 Epidemology     

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)           

                4.1 Market Drivers 

                4.2 Market Restraints                    

                4.3 Key Challenges

                4.4 Current Opportunities in the Market     

5. Market Segmentation                     

                5.1 Product                        

       5.1.1 Introduction           

       5.1.2 Implantable Cardioverter Defibrillators      

       5.1.3 Cardiac Pacemakers            

       5.1.4 Spinal Cord Stimulators      

       5.1.5 Cochlear Implants                

       5.1.6 Deep Brain Stimulators      

       5.1.7 Transcutaneous Electrical Nerve Stimulators            

       5.1.8 Vagus Nerve Stimulators  

       5.1.9 Sacral Nerve Stimulators   

       5.1.10 Retinal Implants 

       5.1.11 Other Electrical Stimulators           

       5.1.12  Y-o-Y Growth Analysis, By Product            

       5.1.13  Market Attractiveness Analysis, By Product          

       5.1.14  Market Share Analysis, By Product            

                5.2 Type of Devices                        

       5.2.1 Introduction           

       5.2.2 Implantable Electroceutical Devices             

       5.2.3 Non-Invasive Electroceutical Devices          

       5.2.4 Y-o-Y Growth Analysis, By Type of Devices               

       5.2.5 Market Attractiveness Analysis, By Type of Devices             

       5.2.6 Market Share Analysis, By Type of Devices               

                5.3 Application                 

       5.3.1 Introduction           

       5.3.2 Arrhythmia             

       5.3.3 Chronic Back Pain 

       5.3.4 Failed Back Syndrome        

       5.3.5 Ischemia  

       5.3.6 Sensorineural Hearing Loss              

       5.3.7 Parkinson’s Disease            

       5.3.8 Tremor     

       5.3.9 Alzheimer's disease            

       5.3.10 Depression           

       5.3.11 Migraine

       5.3.12 Epilepsy 

       5.3.13 Other Applications            

       5.3.14 Y-o-Y Growth Analysis, By Application      

       5.3.15  Market Attractiveness Analysis, By Application   

       5.3.16  Market Share Analysis, By Application     

                5.4 End-Users                   

       5.4.1 Introduction           

       5.4.2 Hospitals  

       5.4.3 Research Institutes             

       5.4.4 Individual Users    

       5.4.5 Y-o-Y Growth Analysis, By End-Users          

       5.4.6  Market Attractiveness Analysis, By End-Users       

       5.4.7  Market Share Analysis, By End-Users         

6. Geographical Analysis                     

                6.1 Introduction      

       6.1.1 Regional Trends    

       6.1.2 Impact Analysis     

       6.1.3 Y-o-Y Growth Analysis        

                       6.1.3.1 By Geographical Area

                       6.1.3.2 By Product

                       6.1.3.3 By Type of Devices

                       6.1.3.4 By Application

                       6.1.3.5 By End-Users

       6.1.4  Market Attractiveness Analysis     

                       6.1.4.1 By Geographical Area

                       6.1.4.2 By Product

                       6.1.4.3 By Type of Devices

                       6.1.4.4 By Application

                       6.1.4.5 By End-Users

       6.1.5  Market Share Analysis      

                       6.1.5.1 By Geographical Area

                       6.1.5.2 By Product

                       6.1.5.3 By Type of Devices

                       6.1.5.4 By Application

                       6.1.5.5 By End-Users

                6.2 Middle-East       

                6.3 Africa   

7. Strategic Analysis               

                7.1 PESTLE analysis

       7.1.1 Political     

       7.1.2 Economic 

       7.1.3 Social         

       7.1.4 Technological         

       7.1.5 Legal          

       7.1.6 Environmental       

                7.2 Porter’s Five analysis     

       7.2.1 Bargaining Power of Suppliers        

       7.2.2 Bargaining Power of Consumers    

       7.2.3 Threat of New Entrants     

       7.2.4 Threat of Substitute Products and Services              

       7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                

                8.1 Medtronic plc   

       8.1.1 Overview 

       8.1.2 Product Analysis   

       8.1.3 Financial analysis  

       8.1.4 Recent Developments       

       8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 St. Jude Medical, Inc.    

                8.3 Boston Scientific Corporation    

                8.4 Cochlear Limited                      

                8.5 Sonova Holding AG                 

                8.6 LivaNova PLC    

                8.7 Biotronik                      

                8.8 Nevro Corporation                  

                8.9 Second Sight Medical Products, Inc.                

                8.10 ElectroCore LLC                      

9. Competitive Landscape                   

                9.1 Market share analysis   

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures

                9.4 New Product Launches

10. Market Outlook and Investment Opportunities                 

11. Appendix                  

                a) List of Tables                

                b) List of Figures     

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and also identifying the regions that are still untapped

  • The segment-level analysis in terms of type Of Device with market size forecasts and estimations to detect key areas of industry growth in detail

  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics

  • Study of the effect of exogenous and endogenous factors that affect the North america market; which includes broadly demographic, economic, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis

  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development

  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis, and analyst overview to study and sustain the market environment

  • Competitive landscape analysis lists out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies, and recent developments in the market by the major companies

  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions

  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

  1. Middle East & Africa Electroceuticals/Bioelectric Medicines Market, By Product, From 2021 to 2026 (USD Billion)

  2. Middle East & Africa Implantable Cardioverter Defibrillators Market, By Region, From 2021 to 2026 (USD Billion)

  3. Middle East & Africa Cardiac Pacemakers  Market, By Region, From 2021 to 2026 (USD Billion)

  4. Middle East & Africa Spinal Cord Stimulators Market, By Region, From 2021 to 2026 (USD Billion)

  5. Middle East & Africa Cochlear Implants Market, By Region, From 2021 to 2026 (USD Billion)

  6. Middle East & Africa Deep Brain Stimulators Market, By Region, From 2021 to 2026 (USD Billion)

  7. Middle East & Africa Transcutaneous Electrical Nerve Stimulators Market, By Region, From 2021 to 2026 (USD Billion)

  8. Middle East & Africa Vagus Nerve Stimulators Market, By Region, From 2021 to 2026 (USD Billion)

  9. Middle East & Africa Sacral Nerve Stimulators Market, By Region, From 2021 to 2026 (USD Billion)

  10. Middle East & Africa Retinal Implants Market, By Region, From 2021 to 2026 (USD Billion)

  11. Middle East & Africa Other Electrical Stimulators Market, By Region, From 2021 to 2026 (USD Billion)

  12. Middle East & Africa Electroceuticals/Bioelectric Medicines Market, By Type of Devices , From 2021 to 2026 (USD Billion)

  13. Middle East & Africa Implantable Electroceutical Devices Market, By Region, From 2021 to 2026 (USD Billion)

  14. Middle East & Africa Non-Invasive Electroceutical Devices Market, By Region, From 2021 to 2026 (USD Billion)

  15. Middle East & Africa Electroceuticals/Bioelectric Medicines Market, By Applications, From 2021 to 2026 (USD Billion)

  16. Middle East & Africa Arrhythmia Market, By Region, From 2021 to 2026 (USD Billion)

  17. Middle East & Africa Chrinic Back Pain Market, By Region, From 2021 to 2026 (USD Billion)

  18. Middle East & Africa Failed Back Syndrome Market, By Region, From 2021 to 2026 (USD Billion)

  19. Middle East & Africa Sensorineural Hearing Loss Market, By Region, From 2021 to 2026 (USD Billion)

  20. Middle East & Africa Parkinson's Disease Market, By Region, From 2021 to 2026 (USD Billion)

  21. Middle East & Africa Treatment-Resistant Depression Market, By Region, From 2021 to 2026 (USD Billion)

  22. Middle East & Africa Epilepsy Market, By Region, From 2021 to 2026 (USD Billion)

  23. Middle East & Africa Retinitis Pigmentosa Market, By Region, From 2021 to 2026 (USD Billion)

  24. Middle East & Africa Migraine Market, By Region, From 2021 to 2026 (USD Billion)

  25. Middle East & Africa Spinal Cord Injury Market, By Region, From 2021 to 2026 (USD Billion)

  26. Middle East & Africa Electroceuticals/Bioelectric Medicines Market, By End User, From 2021 to 2026 (USD Billion)

  27. Middle East & Africa Hospitals Market, By Region, From 2021 to 2026 (USD Billion)

  28. Middle East & Africa Research Institutes Market, By Region, From 2021 to 2026 (USD Billion)

  29. Middle East & Africa Individual Users Market, By Region, From 2021 to 2026 (USD Billion)

  30. Middle East Electroceuticals/Bioelectric Medicines Market, By Product, From 2021 to 2026 (USD Billion)

  31. Middle East Electroceuticals/Bioelectric Medicines Market, By Type of Devices , From 2021 to 2026 (USD Billion)

  32. Middle East Electroceuticals/Bioelectric Medicines Market, By Applications, From 2021 to 2026 (USD Billion)

  33. Middle East Electroceuticals/Bioelectric Medicines Market, By End User, From 2021 to 2026 (USD Billion)

  34. Africa Electroceuticals/Bioelectric Medicines Market, By Product, From 2021 to 2026 (USD Billion)

  35. Africa Electroceuticals/Bioelectric Medicines Market, By Type of Devices, From 2021 to 2026 (USD Billion)

  36. Africa Electroceuticals/Bioelectric Medicines Market, By Applications, From 2021 to 2026 (USD Billion)

  37. Africa Electroceuticals/Bioelectric Medicines Market, By End User, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample